Evidence map›Paper›PMID 40858265›Full record

ArticleThe journal of obstetrics and gynaecology research2025

Clinical analysis of the effect of embryonic outcomes in carriers of chromosomal translocations from different parental sources: A retrospective cohort study of 178 couples.

Yarong Guo, Xinhai Liu, Zehui Xie, Xiaoling Ma

Abstract read
In one paragraph

Article in The journal of obstetrics and gynaecology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yarong GuoThe First School of Clinical Medicine of Lanzhou University, Lanzhou, China.
Xinhai LiuQilihe District People's Hospital, Lanzhou, China.
Zehui XieThe First School of Clinical Medicine of Lanzhou University, Lanzhou, China.
Xiaoling MaThe First School of Clinical Medicine of Lanzhou University, Lanzhou, China.ORCID https://orcid.org/0000-0002-0724-9293

Funding

Gansu Provincial Key Research and Development Plan 21YF1FA115Gansu Provincial Science and Technology Program 20JR10TA715Gansu Provincial Science and Technology Program 21JR7RA391Interdisciplinary project of The First Hospital of Lanzhou University in 2022 ldyyyn2022-22Interdisciplinary project of The First Hospital of Lanzhou University in 2022 ldyyyn2022-39
6 · The paper itself

Abstract

objectiveTo investigate the impact of parental origin (paternal vs. maternal) on embryonic developmental potential and clinical outcomes in carriers of balanced chromosomal translocations; to provide evidence for sex-specific genetic counseling. STUDY

designA total of 178 couples undergoing preimplantation genetic testing for structural rearangement treatment for balanced chromosomal translocations at the Center for Reproductive Medicine, First Hospital of Lanzhou University, between January 2019 and December 2022 were retrospectively included. They were stratified into paternal translocation (n = 75) and maternal translocation (n = 103) groups based on parental origin.

results(1) Sperm quality parameters (progressive motility, immotile sperm, and normal morphology rate) were significantly lower in paternal translocation carriers compared to maternal translocation carriers. (2) Paternal translocation carriers demonstrated significantly higher blastocyst formation rates (59.82% vs. 52.35%, p = 0.006) and high-quality blastocyst rates (38.61% vs. 31.07%, p = 0.034) than maternal translocation carriers. (3) The transferable embryo rate was significantly lower in the maternal translocation group than in the paternal group (p = 0.004). Among abnormal embryos, the maternal group exhibited higher rates of both parental-origin abnormalities (p = 0.012) and complex abnormalities (p = 0.021) compared to the paternal group. (4) The 2:2 alternate segregation rate was significantly higher in the paternal translocation group than in the maternal group (29.67% vs. 39.83%, p = 0.002). Conversely, the 3:1 segregation rate was significantly higher in the maternal translocation group than in the paternal group (26.33% vs. 17.35%, p = 0.002).

conclusionsEmbryos derived from paternal translocation carriers demonstrated significantly higher developmental potential than those from maternal carriers. The elevated rate of de novo chromosomal abnormalities in embryos of maternal translocation carriers underscores the necessity for genetic counseling that differentiates between translocation-associated and incidental genetic anomalies.

Indexed as

Embryonic DevelopmentEmbryo TransferPreimplantation DiagnosisTranslocation, GeneticAdultFemaleHumansMalePregnancyRetrospective Studieschromosomal translocationembryonic geneticsparental originpregnancy outcomespreimplantation genetic testing for structural rearangements (PGT‐SR)

Identifiers

PMID40858265
PMCPMC12380476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.